About Index Trending news
Analyze
Top 50 Pricing
Blueprint Medicines

Blueprint Medicines

Work at Blueprint Medicines? Add yourself to this profile

Blueprint Medicines

Blueprint Medicines discovers and develops highly selective kinase inhibitors for patients with genomically defined cancers

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding Show all
Venture capital (Series C)
$50,000,000
Venture capital (Series B)
$25,000,000
Employees

Team size

10+
Locations
HQ
Xconomy

Blueprint, Roche Ink Milestone Deal for Cancer Immunotherapy